APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kidney Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Kidney Medicine Industry Growth and Trends Forecast to 2032

23 December 2025106 pages

Choose your research edition.

Industry ResearchKidney Medicine Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Kidney Medicine Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Kidney Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kidney Medicine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Kidney Medicine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Kidney Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Kidney Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Kidney Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kidney Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Kidney Medicine include Xiuzheng Pharmaceutical Group, Xiaolin Zhiyao, Sanofi, Novartis, Roche, Henan Lingrui Pharmaceutical, Kuihua yaoye, Pfizer and Sanjiu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Kidney Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Kidney Medicine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Kidney Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Kidney Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Kidney Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Kidney Medicine Market by Company

Xiuzheng Pharmaceutical Group

Xiaolin Zhiyao

Sanofi

Novartis

Roche

Henan Lingrui Pharmaceutical

Kuihua yaoye

Pfizer

Sanjiu Pharmaceutical

Harbin Pharmaceutical Group

Amgen

Kidney Medicine Segment by Type

Tablet

Oral Liquid

Capsule

Kidney Medicine Segment by Application

Hospital

Pharmacy

Others

Kidney Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kidney Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Kidney Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Kidney Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Oral Liquid Table 3. Major Company of Capsule Table 4. Global Kidney Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Kidney Medicine Sales by Type (2021-2026) & (k units) Table 6. Global Kidney Medicine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Kidney Medicine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Kidney Medicine Sales Market Share in Value by Type (2021-2026) Table 9. Global Kidney Medicine Price by Type (2021-2026) & (US$/unit) Table 10. Global Kidney Medicine Sales by Type (2027-2032) & (k units) Table 11. Global Kidney Medicine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Kidney Medicine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Kidney Medicine Sales Market Share in Value by Type (2027-2032) Table 14. Global Kidney Medicine Price by Type (2027-2032) & (US$/unit) Table 15. North America Kidney Medicine Sales by Type (2021-2026) & (k units) Table 16. North America Kidney Medicine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Kidney Medicine Sales by Type (2021-2026) & (k units) Table 18. Europe Kidney Medicine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Kidney Medicine Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Kidney Medicine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Kidney Medicine Sales by Type (2021-2026) & (k units) Table 22. Latin America Kidney Medicine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Kidney Medicine Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Kidney Medicine Sales by Type (2021-2026) & (US$ Million) Table 25. Kidney Medicine Industry Trends Table 26. Kidney Medicine Industry Drivers Table 27. Kidney Medicine Industry Opportunities and Challenges Table 28. Kidney Medicine Industry Restraints Table 29. Global Kidney Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Kidney Medicine Revenue Market Share by Company (2021-2026) Table 31. Global Kidney Medicine Sales by Company (2021-2026) & (k units) Table 32. Global Kidney Medicine Sales Share by Company (2021-2026) Table 33. Global Kidney Medicine Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Kidney Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Kidney Medicine Major Company Production Sites and Headquarters Table 36. Global Kidney Medicine Company, Product Type & Application Table 37. Global Kidney Medicine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Kidney Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Kidney Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Kidney Medicine Sales by Region (2021-2026) & (k units) Table 42. Global Kidney Medicine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Kidney Medicine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Kidney Medicine Sales Market Share in Value by Region (2021-2026) Table 45. Global Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Kidney Medicine Sales by Region (2027-2032) & (k units) Table 47. Global Kidney Medicine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Kidney Medicine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Kidney Medicine Sales Market Share in Value by Region (2027-2032) Table 50. Global Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Kidney Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Kidney Medicine Sales by Application (2021-2026) & (k units) Table 53. Global Kidney Medicine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Kidney Medicine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Kidney Medicine Sales Market Share in Value by Application (2021-2026) Table 56. Global Kidney Medicine Price by Application (2021-2026) & (US$/unit) Table 57. Global Kidney Medicine Sales by Application (2027-2032) & (k units) Table 58. Global Kidney Medicine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Kidney Medicine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Kidney Medicine Sales Market Share in Value by Application (2027-2032) Table 61. Global Kidney Medicine Price by Application (2027-2032) & (US$/unit) Table 62. North America Kidney Medicine Sales by Application (2021-2026) & (k units) Table 63. North America Kidney Medicine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Kidney Medicine Sales by Application (2021-2026) & (k units) Table 65. Europe Kidney Medicine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Kidney Medicine Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Kidney Medicine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Kidney Medicine Sales by Application (2021-2026) & (k units) Table 69. Latin America Kidney Medicine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Kidney Medicine Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Kidney Medicine Sales by Application (2021-2026) & (US$ Million) Table 72. Xiuzheng Pharmaceutical Group Company Information Table 73. Xiuzheng Pharmaceutical Group Business Overview Table 74. Xiuzheng Pharmaceutical Group Kidney Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Xiuzheng Pharmaceutical Group Kidney Medicine Product Portfolio Table 76. Xiuzheng Pharmaceutical Group Recent Development Table 77. Xiaolin Zhiyao Company Information Table 78. Xiaolin Zhiyao Business Overview Table 79. Xiaolin Zhiyao Kidney Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Xiaolin Zhiyao Kidney Medicine Product Portfolio Table 81. Xiaolin Zhiyao Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Kidney Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Sanofi Kidney Medicine Product Portfolio Table 86. Sanofi Recent Development Table 87. Novartis Company Information Table 88. Novartis Business Overview Table 89. Novartis Kidney Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Novartis Kidney Medicine Product Portfolio Table 91. Novartis Recent Development Table 92. Roche Company Information Table 93. Roche Business Overview Table 94. Roche Kidney Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Roche Kidney Medicine Product Portfolio Table 96. Roche Recent Development Table 97. Henan Lingrui Pharmaceutical Company Information Table 98. Henan Lingrui Pharmaceutical Business Overview Table 99. Henan Lingrui Pharmaceutical Kidney Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Henan Lingrui Pharmaceutical Kidney Medicine Product Portfolio Table 101. Henan Lingrui Pharmaceutical Recent Development Table 102. Kuihua yaoye Company Information Table 103. Kuihua yaoye Business Overview Table 104. Kuihua yaoye Kidney Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Kuihua yaoye Kidney Medicine Product Portfolio Table 106. Kuihua yaoye Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Kidney Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Pfizer Kidney Medicine Product Portfolio Table 111. Pfizer Recent Development Table 112. Sanjiu Pharmaceutical Company Information Table 113. Sanjiu Pharmaceutical Business Overview Table 114. Sanjiu Pharmaceutical Kidney Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Sanjiu Pharmaceutical Kidney Medicine Product Portfolio Table 116. Sanjiu Pharmaceutical Recent Development Table 117. Harbin Pharmaceutical Group Company Information Table 118. Harbin Pharmaceutical Group Business Overview Table 119. Harbin Pharmaceutical Group Kidney Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Harbin Pharmaceutical Group Kidney Medicine Product Portfolio Table 121. Harbin Pharmaceutical Group Recent Development Table 122. Amgen Company Information Table 123. Amgen Business Overview Table 124. Amgen Kidney Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Amgen Kidney Medicine Product Portfolio Table 126. Amgen Recent Development Table 127. North America Kidney Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. North America Kidney Medicine Sales by Country (2021-2026) & (k units) Table 129. North America Kidney Medicine Sales Market Share by Country (2021-2026) Table 130. North America Kidney Medicine Sales Forecast by Country (2027-2032) & (k units) Table 131. North America Kidney Medicine Sales Market Share Forecast by Country (2027-2032) Table 132. North America Kidney Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Kidney Medicine Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Kidney Medicine Market Share by Country (2021-2026) Table 135. North America Kidney Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Kidney Medicine Market Share Forecast by Country (2027-2032) Table 137. Europe Kidney Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Europe Kidney Medicine Sales by Country (2021-2026) & (k units) Table 139. Europe Kidney Medicine Sales Market Share by Country (2021-2026) Table 140. Europe Kidney Medicine Sales Forecast by Country (2027-2032) & (k units) Table 141. Europe Kidney Medicine Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Kidney Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Kidney Medicine Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Kidney Medicine Market Share by Country (2021-2026) Table 145. Europe Kidney Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Kidney Medicine Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Kidney Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Kidney Medicine Sales by Country (2021-2026) & (k units) Table 149. Asia-Pacific Kidney Medicine Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Kidney Medicine Sales Forecast by Country (2027-2032) & (k units) Table 151. Asia-Pacific Kidney Medicine Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Kidney Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Kidney Medicine Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Kidney Medicine Market Share by Country (2021-2026) Table 155. Asia-Pacific Kidney Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Kidney Medicine Market Share Forecast by Country (2027-2032) Table 157. Latin America Kidney Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Latin America Kidney Medicine Sales by Country (2021-2026) & (k units) Table 159. Latin America Kidney Medicine Sales Market Share by Country (2021-2026) Table 160. Latin America Kidney Medicine Sales Forecast by Country (2027-2032) & (k units) Table 161. Latin America Kidney Medicine Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Kidney Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Kidney Medicine Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Kidney Medicine Market Share by Country (2021-2026) Table 165. Latin America Kidney Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Kidney Medicine Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Kidney Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Kidney Medicine Sales by Country (2021-2026) & (k units) Table 169. Middle East and Africa Kidney Medicine Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Kidney Medicine Sales Forecast by Country (2027-2032) & (k units) Table 171. Middle East and Africa Kidney Medicine Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Kidney Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Kidney Medicine Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Kidney Medicine Market Share by Country (2021-2026) Table 175. Middle East and Africa Kidney Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Kidney Medicine Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Kidney Medicine Distributors List Table 180. Kidney Medicine Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Kidney Medicine Image Figure 2. Global Kidney Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kidney Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Kidney Medicine Sales (2021-2032) & (k units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (k units) Figure 7. Oral Liquid Image Figure 8. Global Oral Liquid Sales YoY Growth (2021-2032) & (k units) Figure 9. Capsule Image Figure 10. Global Capsule Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Kidney Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Kidney Medicine Market Share by Type 2025 VS 2032 Figure 13. North America Kidney Medicine Sales Market Share in Volume by Type in 2025 Figure 14. North America Kidney Medicine Sales Market Share in Value by Type in 2025 Figure 15. Europe Kidney Medicine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Kidney Medicine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Kidney Medicine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Kidney Medicine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Kidney Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Kidney Medicine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Kidney Medicine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Kidney Medicine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Kidney Medicine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Kidney Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Kidney Medicine Market Share by Application 2025 VS 2032 Figure 33. North America Kidney Medicine Sales Market Share in Volume by Application in 2025 Figure 34. North America Kidney Medicine Sales Market Share in Value by Application in 2025 Figure 35. Europe Kidney Medicine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Kidney Medicine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Kidney Medicine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Kidney Medicine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Kidney Medicine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Kidney Medicine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Kidney Medicine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Kidney Medicine Sales Market Share in Value by Application in 2025 Figure 43. North America Kidney Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Kidney Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Kidney Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Kidney Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Kidney Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Kidney Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Kidney Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Kidney Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Kidney Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Kidney Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Kidney Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Kidney Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Kidney Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Kidney Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Kidney Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Kidney Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Kidney Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Kidney Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Kidney Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Kidney Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Kidney Medicine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Kidney Medicine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Liquid
  • Capsule
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Xiuzheng Pharmaceutical Group
  • Xiaolin Zhiyao
  • Sanofi
  • Novartis
  • Roche
  • Henan Lingrui Pharmaceutical
  • Kuihua yaoye
  • Pfizer
  • Sanjiu Pharmaceutical
  • Harbin Pharmaceutical Group
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Kidney Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Kidney Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Kidney Medicine Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Oral Liquid
  8. 1.3.3 Capsule
  9. 1.4 Global Kidney Medicine Market Size by Type
  10. 1.4.1 Global Kidney Medicine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Kidney Medicine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Kidney Medicine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Kidney Medicine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Kidney Medicine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Kidney Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Kidney Medicine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Kidney Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Kidney Medicine Industry Trends
  2. 2.2 Kidney Medicine Industry Drivers
  3. 2.3 Kidney Medicine Industry Opportunities and Challenges
  4. 2.4 Kidney Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Kidney Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Kidney Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Kidney Medicine Price (2021-2026)
  4. 3.4 Global Kidney Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Kidney Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Kidney Medicine Company, Product Type & Application
  7. 3.7 Global Kidney Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Kidney Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Kidney Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Kidney Medicine Tier 1, Tier 2, and Tier 3
4 Kidney Medicine Regional Status and Outlook
  1. 4.1 Global Kidney Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Kidney Medicine Historic Market Size by Region
  3. 4.2.1 Global Kidney Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Kidney Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Kidney Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Kidney Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Kidney Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Kidney Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Kidney Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Kidney Medicine by Application
  1. 5.1 Kidney Medicine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Kidney Medicine Market Size by Application
  6. 5.2.1 Global Kidney Medicine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Kidney Medicine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Kidney Medicine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Kidney Medicine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Kidney Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Kidney Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Kidney Medicine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Kidney Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Xiuzheng Pharmaceutical Group
  2. 6.1.1 Xiuzheng Pharmaceutical Group Company Information
  3. 6.1.2 Xiuzheng Pharmaceutical Group Business Overview
  4. 6.1.3 Xiuzheng Pharmaceutical Group Kidney Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Xiuzheng Pharmaceutical Group Kidney Medicine Product Portfolio
  6. 6.1.5 Xiuzheng Pharmaceutical Group Recent Developments
  7. 6.2 Xiaolin Zhiyao
  8. 6.2.1 Xiaolin Zhiyao Company Information
  9. 6.2.2 Xiaolin Zhiyao Business Overview
  10. 6.2.3 Xiaolin Zhiyao Kidney Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Xiaolin Zhiyao Kidney Medicine Product Portfolio
  12. 6.2.5 Xiaolin Zhiyao Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Kidney Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Kidney Medicine Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Kidney Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Kidney Medicine Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Kidney Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche Kidney Medicine Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Henan Lingrui Pharmaceutical
  32. 6.6.1 Henan Lingrui Pharmaceutical Company Information
  33. 6.6.2 Henan Lingrui Pharmaceutical Business Overview
  34. 6.6.3 Henan Lingrui Pharmaceutical Kidney Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Henan Lingrui Pharmaceutical Kidney Medicine Product Portfolio
  36. 6.6.5 Henan Lingrui Pharmaceutical Recent Developments
  37. 6.7 Kuihua yaoye
  38. 6.7.1 Kuihua yaoye Company Information
  39. 6.7.2 Kuihua yaoye Business Overview
  40. 6.7.3 Kuihua yaoye Kidney Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kuihua yaoye Kidney Medicine Product Portfolio
  42. 6.7.5 Kuihua yaoye Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Kidney Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Kidney Medicine Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Sanjiu Pharmaceutical
  50. 6.9.1 Sanjiu Pharmaceutical Company Information
  51. 6.9.2 Sanjiu Pharmaceutical Business Overview
  52. 6.9.3 Sanjiu Pharmaceutical Kidney Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sanjiu Pharmaceutical Kidney Medicine Product Portfolio
  54. 6.9.5 Sanjiu Pharmaceutical Recent Developments
  55. 6.10 Harbin Pharmaceutical Group
  56. 6.10.1 Harbin Pharmaceutical Group Company Information
  57. 6.10.2 Harbin Pharmaceutical Group Business Overview
  58. 6.10.3 Harbin Pharmaceutical Group Kidney Medicine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Harbin Pharmaceutical Group Kidney Medicine Product Portfolio
  60. 6.10.5 Harbin Pharmaceutical Group Recent Developments
  61. 6.11 Amgen
  62. 6.11.1 Amgen Company Information
  63. 6.11.2 Amgen Business Overview
  64. 6.11.3 Amgen Kidney Medicine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Amgen Kidney Medicine Product Portfolio
  66. 6.11.5 Amgen Recent Developments
7 North America by Country
  1. 7.1 North America Kidney Medicine Sales by Country
  2. 7.1.1 North America Kidney Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Kidney Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Kidney Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Kidney Medicine Market Size by Country
  6. 7.2.1 North America Kidney Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Kidney Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Kidney Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Kidney Medicine Sales by Country
  2. 8.1.1 Europe Kidney Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Kidney Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Kidney Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Kidney Medicine Market Size by Country
  6. 8.2.1 Europe Kidney Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Kidney Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Kidney Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Kidney Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Kidney Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Kidney Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Kidney Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Kidney Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Kidney Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Kidney Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Kidney Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Kidney Medicine Sales by Country
  2. 10.1.1 South America Kidney Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Kidney Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Kidney Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Kidney Medicine Market Size by Country
  6. 10.2.1 South America Kidney Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Kidney Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Kidney Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Kidney Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Kidney Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Kidney Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Kidney Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Kidney Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Kidney Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Kidney Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Kidney Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Kidney Medicine Value Chain Analysis
  2. 12.1.1 Kidney Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Kidney Medicine Production Mode & Process
  7. 12.2 Kidney Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Kidney Medicine Distributors
  10. 12.2.3 Kidney Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst